Industry Insight
Information, Observation & Analysis
With influenza apparently returning with a vengeance this season, the Centers for Disease Control and Prevention is once again alerting the public that vaccination is the most effective way to prevent infection from and to minimize risk of severe symptoms and hospitalization for serious flu-related complications.
While the COVID-19 pandemic is "officially over," hospitalizations and deaths continue, many of which are due to the myths continuing to circulate about this deadly virus.
Research into effective treatments for this complicated disease is elusive — and necessary.
The pandemic made a troubling mental health trend in children much worse. What's being done to help them?
While a cure for Alzheimer’s remains elusive, new diagnostic tools and treatment options are improving patient quality of life.
Exciting new developments in gene therapy and genome editing show promise for treating a variety of genetic diseases.
Do the advantages of virtual care outweigh the drawbacks? Patients seem to think so.
RSV infections account for a large share of U.S. hospitalizations for lower respiratory tract disease due in large part to a lack of immunization and prophylactic therapies, but new developments and cutting-edge therapies may soon become standard medical practice.
Proposed rules revising the Medicare Hospital Outpatient Prospective Payment System (OPPS) and the Medicare Ambulatory Surgical Center (ASC) services, along with new physician fee schedule (PFS) rule sets will significantly impact providers in 2023.
The best way to help individuals suffering from depression is to spread awareness about the misconceptions surrounding this mood disorder.
The implementation of vaccine passports in response to the COVID-19 pandemic has raised arguments for and against them.
An ultrarare autosomal recessive disorder, congenital plasminogen deficiency (PLGD) results from inheritance of defective copies of both alleles of the PLG gene, which yields dysfunctional or too little plasminogen. The end result is impaired extracellular fibrin clearance during wound healing, presenting on affected mucous membranes throughout the body as accumulations of nondegraded fibrin as pseudomembranous ligneous — “woody” — growths.